András Lakatos

András Lakatos

Auto-generated profile, based on publicly available information

András Lakatos

John van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 February 2021 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
CECarole Escartin
Carole Escartin
EGElena Galea
Elena Galea
ALAndrás Lakatos
András Lakatos
JOJames P. O’cAllaghan
James P. O’cAllaghan
GPGabor C. Petzold
Gabor C. Petzold
Alexei VerkhratskyAlexei Verkhratsky
Alexei Verkhratsky

18 March 2019 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
SGStefano L. Giandomenico
Stefano L. Giandomenico
SMSusanna B. Mierau
Susanna B. Mierau
GGGeorge M. Gibbons
George M. Gibbons
LWLea M. D. Wenger
Lea M. D. Wenger
LMLaura Masullo
Laura Masullo
MLMadeline A. Lancaster
Madeline A. Lancaster


21 October 2021 in Nature Neuroscience
Verified
Journal Article
Open access
PDF file
KSKornélia Szebényi
Kornélia Szebényi
LWLéa M. D. Wenger
Léa M. D. Wenger
YSYu Sun
Yu Sun
ADAlexander W. E. Dunn
Alexander W. E. Dunn
CLColleen A. Limegrover
Colleen A. Limegrover
ALAndrás Lakatos
András Lakatos
Amyotrophic lateral sclerosis overlapping with frontotemporal dementia (ALS/FTD) is a fatal and currently untreatable disease characterized by rapid cognitive decline and paralysis. Elucidating initial cellular pathologies is central to therapeutic target development, but obtaining samples from presymptomatic patients is not feasible. Here, we report the development of a cerebral organoid slice model derived from human induced pluripotent stem cells (iPSCs) that recapitulates mature cortical architecture and displays early molecular pathology of C9ORF72 ALS/FTD. Using a combination of single-cell RNA sequencing and biological assays, we reveal distinct transcriptional, proteostasis and DNA repair disturbances in astroglia and neurons. We show that astroglia display increased levels of the autophagy signaling protein P62 and that deep layer neurons accumulate dipeptide repeat protein poly(GA), DNA damage and undergo nuclear pyknosis that could be pharmacologically rescued by GSK2606414. Thus, patient-specific iPSC-derived cortical organoid slice cultures are a reproducible translational platform to investigate preclinical ALS/FTD mechanisms as well as novel therapeutic approaches.

1 May 2017 in Cell Reports
Verified
Journal Article
Open access
CHClaire E. Hall
Claire E. Hall
ZYZhi Yao
Zhi Yao
MCMinee Choi
Minee Choi
GTGiulia E. Tyzack
Giulia E. Tyzack
ASAndrea Serio
Andrea Serio
RPRickie Patani
Rickie Patani
Motor neurons (MNs) and astrocytes (ACs) are implicated in the pathogenesis of amyotrophic lateral sclerosis (ALS), but their interaction and the sequence of molecular events leading to MN death remain unresolved. Here, we optimized directed differentiation of induced pluripotent stem cells (iPSCs) into highly enriched (> 85%) functional populations of spinal cord MNs and ACs. We identify significantly increased cytoplasmic TDP-43 and ER stress as primary pathogenic events in patient-specific valosin-containing protein (VCP)-mutant MNs, with secondary mitochondrial dysfunction and oxidative stress. Cumulatively, these cellular stresses result in synaptic pathology and cell death in VCP-mutant MNs. We additionally identify a cell-autonomous VCP-mutant AC survival phenotype, which is not attributable to the same molecular pathology occurring in VCP-mutant MNs. Finally, through iterative co-culture experiments, we uncover non-cell-autonomous effects of VCP-mutant ACs on both control and mutant MNs. This work elucidates molecular events and cellular interplay that could guide future therapeutic strategies in ALS.